Key result
Pretreatment with an ACE inhibitor or AT(1)-receptor antagonist significantly attenuated the LPS-induced increase in hepatic IL-1beta and plasma IL-6 in dehydrated rats.
This study provides the first in vivo evidence that ANG II and its AT1 receptor mediate LPS-induced proinflammatory cytokine production under dehydrated conditions.
Extends RAS-cytokine interactions to dehydration models; hypothesis-generating and requires human validation before clinical consideration.
We have previously reported results that led us to speculate that ANG II is involved in the LPS-induced production of proinflammatory cytokines, especially under dehydrated conditions. To test this possibility, in this study we examined the effects of an angiotensin-converting enzyme (ACE) inhibitor and an antagonist of the type-1 ANG II receptor (AT(1) receptor) on the LPS-induced production of the proinflammatory cytokines IL-1 and IL-6 in dehydrated rats. A single intravenous injection of LPS induced a marked increase in the expression of IL-1beta mRNA in the liver, an effect that was significantly attenuated by pretreatment with the ACE inhibitor. Furthermore, the ACE inhibitor reduced the LPS-induced increase in the hepatic concentration of IL-1beta protein. When the AT(1)-receptor antagonist was given intravenously before the LPS, the increase in the hepatic concentration of IL-1beta was significantly reduced. Finally, the ACE inhibitor reduced the LPS-induced increase in the plasma concentration of IL-6. These results represent the first in vivo evidence that ANG II and its AT(1) receptor play important roles in the production of proinflammatory cytokines that is induced by LPS under dehydrated conditions.
No takes yet. Share an insight, caveat, or question.
Miyoshi et al. (2003) studied LPS-induced inflammation in dehydration. ACE inhibitor and AT(1)-receptor antagonist vs. LPS alone (implied) was evaluated on LPS-induced production of proinflammatory cytokines IL-1 and IL-6. Pretreatment with an ACE inhibitor or AT(1)-receptor antagonist significantly attenuated the LPS-induced increase in hepatic IL-1beta and plasma IL-6 in dehydrated rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: